Full text is available at the source.
Development of New Chronopharmacotherapies Based on Biological Rhythm
Developing new medicines that work with the body's natural daily rhythms
AI simplified
Abstract
Interferon disrupts the rhythm of locomotor activity, body temperature, and clock gene expression in mammals.
- The mammalian circadian pacemaker is located in the suprachiasmatic nuclei (SCN).
- Clock genes manage circadian rhythms that influence physiology and behavior.
- Drug effectiveness and toxicity may vary based on the timing of administration relative to circadian rhythms.
- Monitoring rhythmic markers could aid in selecting optimal dosing times for medications.
- Some drugs can negatively impact 24-hour rhythms, potentially leading to health issues.
- Dosing schedules that minimize the adverse effects on clock function may enhance chronopharmacotherapy.
AI simplified